-
Marchés
-
Actions
Sustainable finance2025 Euronext ESG Trends ReportLire la suiteA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLire la suiteThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETF
The European market place for ETFsEuronext ETF EuropeLire la suiteInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fonds
-
Obligations
European Defence BondsGroupe BPCE lists the first bondLire la suiteFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Produits Structurés
-
Dérivés
Where European Government Bonds Meet the FutureFixed Income derivativesLire la suiteTrade mini bond futures on main European government bonds
-
Marchandises
- Vue d'ensemble
- Vue d'ensemble
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Règlement livraison
- Spécifications et dispositions
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesLire la suiteEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Ressources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameLire la suiteJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
OCTOPLUS
Identification
Listing sponsor / Agent
FORTIS
Symbole
OCTO
Code ISIN
NL0000345718
Trading location
Amsterdam
ICB
Biotechnology
Description de l'activité
The issuer was founded in 1995 and is a product-oriented biopharmaceutical company committed to the development of improved pharmaceutical products that are based on proprietary drug delivery technologies of the company and have fewer side effects, increased patient convenience and better efficacy than existing therapies.
Site internet
http://www.octoplus.nl/index.cfm/octoplus
Operation
Date de l'IPO
lun 03/12/2007
IPO type
Introduction by public issue of new shares
Type d'IPO
Initial Public offering
Catégorie
IPO
Operation description
Offering of up to 4,9 million newly issued ordinary shares, at a price range of EUR 4,65 to EUR 5,50 per Share.
Operation calendar
Date of first listing: 4 October 2006 Settlement: 9 october 2006